Inventor

OLSON ERIC N

US36 patents

⚠️ This page may combine multiple inventors who share the name “OLSON ERIC N”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

OLSON ERIC N

UNIV TEXAS

Transgenic animal models for cardiac hypertrophy and methods of use thereof

Inhibition of histone deacetylase as a treatment for cardiac hypertrophy

Transgenic mouse comprising a MEF2 binding site operatively linked to an indicator gene and methods of use

Smooth muscle 22α promoter, gene transfer vectors containing the same, and method of use of the same to target gene expression in arterial smooth muscle cells

Smooth muscle 22α promoter, gene transfer vectors containing the same, and method of use of the same to target gene expression in arterial smooth muscle cells

Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression

Micro-RNA family that modulates fibrosis and uses thereof

Micro-RNA family that modulates fibrosis and uses thereof

Micro-RNA family that modulates fibrosis and uses thereof

Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes

Micro-RNA family that modulates fibrosis and uses thereof

Micro-RNA family that modulates fibrosis and uses thereof

Micro-RNA family that modulates fibrosis and uses thereof

Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating)

Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload

Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload

Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload

Micro-RNAS that control myosin expression and myofiber identity

Transgenic mice comprising a constitutively-activated MEK5 and exhibiting cardiac hypertrophy and dilated cardiomyopathy

NURR1 activation in the treatment of metabolic disorders and as an exercise mimetic

Micro-RNA family that modulates extracellular matrix genes and uses thereof

Micro-RNAs of the miR-15 family modulate cardiomyocyte survival and cardiac repair

Stem cell differentiating agents and uses therefor

Methods and compositions relating to a cardiac-specific nuclear regulatory factor

Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression

Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells

Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells

Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells

Modulation of MRTF-A activity in pathologic fibrosis and wound healing

OLSON ERIC N

Stem cell differentiating agents and uses therefor

Regulation of metabolism by miR-378

Antimir-451 for the treatment of polycythemias

Identification of micro-RNAs involved in post-myocardial infarction remodeling and heart failure

UNIV COLORADO

Inhibition of histone deacetylase as a treatment for cardiac hypertrophy

NAM YOUNG-JAE

Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes

TEXAS SYSTEMS UNIVERSITY OF TH

Transgenic mouse model for cardiac hypertrophy and methods of use thereof